IL6R and adenocarcinoma: In contrast to the results of other investigators, Balabko et al. note the presence of complicated interactions between Th17 lymphocytes, IL-6R and the pSTAT3/BATF/RorγT-axis in adenocarcinoma as compared to SCC of the lung, and higher expression of IL-6R in AC than SCC40.